KIAA2013 Monoklonaler Antikörper
KIAA2013 Monoklonal Antikörper für WB, IF/ICC, Indirect ELISA
Wirt / Isotyp
Maus / IgG2b
Getestete Reaktivität
human, Ratte
Anwendung
WB, IF/ICC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
4G6C4
Kat-Nr. : 68245-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
68245-1-PBS bindet in WB, IF/ICC, Indirect ELISA KIAA2013 und zeigt Reaktivität mit human, Ratten
| Getestete Reaktivität | human, Ratte |
| Wirt / Isotyp | Maus / IgG2b |
| Klonalität | Monoklonal |
| Typ | Antikörper |
| Immunogen | KIAA2013 fusion protein Ag27438 |
| Vollständiger Name | KIAA2013 |
| Beobachtetes Molekulargewicht | 65 kDa |
| GenBank-Zugangsnummer | BC035033 |
| Gene symbol | KIAA2013 |
| Gene ID (NCBI) | 90231 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
KIAA2013, also known as Q8IYS2 or MGC33867, is a single-pass transmembrane protein encoded by the KIAA2013 gene in humans. KIAA2013 has been found to play a role in the Endocannabinoid system. This system is made up of cannabinoid receptors 1 and 2 (CB1 and CB2) as well as the various ligands and enzymes that interact. The protein KIAA2013 has been found to be expressed within CB2 expressing cells. Both cannabinoid receptors are labeled as class A G-Protein Coupled Receptors, and CB2 is highly expressed within the human spleen and leukocytes. CB2, and by extension KIAA2013, are therefore targets of interest for therapeutic studies looking into diseases such as inflammatory bowel disease and rheumatoid arthritis(PMID:31616248 34752341).





